Pulmonary alveolar microlithiasis (PAM) is a rare disease characterized by the presence of small calculi in the alveolar space. The SLC34A2 is thought to be responsible for the disease. We encountered three siblings of an inbred family who have PAM. We examined the family of the proband who was admitted with dyspnea on exertion and cough, and eventually was diagnosed with PAM. Genetic analysis revealed that both parents (a consanguineous marriage) of the proband were carriers with heterozygous mutation of SLC34A2 gene, and three of their children were diagnosed with PAM with homozygous mutation in the SLC34A2 gene. These findings suggest that impaired activity of the SLC34A2 gene may be responsible for familial PAM.
Introduction
Pulmonary alveolar microlithiasis (PAM) is a rare disease characterized by the presence of small calculi (calcium phosphate) in the alveolar space (1) (2) (3) . PAM is more prevalent in some countries such as Italy, USA, and Turkey, as well as Japan. Turkey represents 30% of the worldwide literature on PAM (1, (4) (5) (6) . The disease is predominant in men, especially among sporadic cases in Turkey. About onethird of the reported cases are familial and the man to woman ratio is equal in familial cases (1) (2) (3) . Hypothetical mechanisms for the etiology and pathogenesis of the disease are an inborn error of metabolism, an unusual response to an unspecified pulmonary insult, an immune reaction to various irritants, and acquired abnormality of calcium and phosphorus metabolism (7) . In contrast, as horizontal transmission among siblings born to unaffected patients has been shown and a high rate of consanguinity was present among the parents of the affected individuals, PAM has been considered to be an autosomal recessive disorder (3, 8) . Re-cently, a few reports have described the role of mutation in the SCL34A2 gene (the type IIb sodium-phosphate cotransporter gene) (8, 9) . Here, we describe mutations in SLC34A 2 gene in an inbred Turkish family with three siblings diagnosed as PAM.
Subjects
Mutation screening of the SLC34A2 gene in six members of the family of the index case was performed. Written informed consent was obtained from all subjects or their parents.
Sibling 1. (proband)
A 28-year-old man presented with dyspnea on exertion and cough. Bibasilar fine crackles were heard on chest auscultation. Hematology, biochemistry and urinalysis were within normal limits. His chest radiograph showed the presence of bilateral micronodular calcified densities, involving mid-and lower zones of lungs, obliterating cardiac, mediastinal, and diaphragmatic borders. 
a : Ch e s t r a d i o g r a p h y o f t h e p r o b a n d . B i l a t e r a l mi c r o n o d u l a r c a l c i f i e d d e n s i t i e s c h a r a c t e r i s t i c " s a n d -s t o r m" l i k e p i c t u r e , c o n c e n t r a t e d i n t h e mi d d l e a n d l o we r l u n g z o ne s , o b l i t e r a t i n g c a r d i a c , me d i a s t i n a l , a n d d i a p h r a g ma t i c b o r d e r s . b : Me d i a s t i n a l wi n d o w f r o m a s t a n d a r d c o mp u t e ri z e d t o mo g r a p h y o f t h e c h e s t s h o ws e x t e n s i v e c a l c i f i c a t i o n wi t h i n t h e l u n g p a r e n c h y ma , wh i c h wa s p r o mi n e n t i n t h e l o we r l u n g z o n e s . a b F i g u r e 2 . Ch e s t r a d i o g r a p h o f t h e 1 1 -y e a r -o l d s i s t e r o f t h e p r o b a n d s h o ws b i l a t e r a l mi c r o n o d u l a r c a l c i f i e d d e n s i t i e s wi t h o u t c o n g l o me r a t i o n s .
extensive conglomeration (Fig. 1a, b ). Pulmonary function tests showed a mild restrictive pattern; forced vital capacity (FVC) of 3.39 L (69% predicted); a forced expiratory volume in 1 s (FEV1) of 2.89 L (75% predicted) and an FEV1/ FVC ratio of 0.87. Single breath carbon monoxide diffusion capacity (DLCO) showed a DLCO of 6.3 mmol/kPa/min (75% predicted), and adjusted DLCO/VA of 1.64 mmol/kPa/ min (128% of predicted). Room air arterial blood gas analysis demonstrated mild hypercapnia (PaCO2 47 Torr, PO2 77 Torr, O2 saturation 96%, and pH 7.44). Bone scintigraphy revealed bilateral intense 99 mTc uptake in the lung. There was no history of exposure to dust or fumes, and sputum smear and culture for acid-fast bacilli were negative. The histological examination of transbronchial biopsy confirmed the diagnosis of PAM. He said that his brother had similar symptoms; therefore, we invited the family members for examination.
Mother
A 54-year-old obese woman complained of dyspnea on exertion. She was a self-reported never smoker and was using antihypertensive medication. Her physical examination was normal. Routine laboratory examination including complete blood count, biochemistry and urinalysis were normal, as well as chest radiography.
Father
A symptom-free 51-year-old farmer, self-reported current smoker (40 pack/years). His physical examination was normal. Routine laboratory examination including complete blood count, biochemistry and urinalysis were normal, as well as chest radiography.
Sibling 3.
Brother One year older than proband (29 years old). He suffered from cough, dyspnea on exertion, nausea, and headache. Breath sounds were diminished on chest auscultation, particularly at the lower lung zones. Bibasilar fine crackles were heard. Erythrocyte sedimentation rate was 52 mm/h. His blood urea nitrogen and creatinine levels were 62 mg/dL and 5.7 mg/dL, respectively. Bilateral diffuse micronodules were observed on chest radiography. Calcified micronodules with rare conglomeration were seen on HRCT. Pulmonary function tests showed a FVC of 3.80 L (75% predicted); a FEV1 of 3.03 L (71% predicted) and an FEV1/FVC ratio of 0.80. Diffusion capacity studies showed a DLCO of 7.1 mmol/kPa/min (60% predicted), and DLCO/VA of 1.38 mmol/kPa/min (64% predicted). Room air arterial blood gas analysis demonstrated mild hypoxemia (PO2 58 Torr PaCO2 35 Torr, O2 saturation 90%, and pH 7.46). Scintigraphy revealed bilateral intense 99 mTc uptake in the lungs. He was diagnosed with renal failure because of hypertension, and began to receive dialysis three times a week.
Sibling 7.
The 11-year-old sister of the index case complained of loss of appetite and dyspnea on exertion. Routine laboratory examination including complete blood count, biochemistry and urinalysis were normal. Chest X-ray revealed, although not intense, diffuse micronodular infiltration (Fig. 2) .
F i g u r e 3 . P e d i g r e e a n d mu t a t i o n s o f t h e S L C3 4 A2 i n a l l a v a i l a b l e me mb e r s o f f a mi l y i n c l u d i n g t h r e e s i b l i n g s ( 1 , 3 a n d 7 ) wi t h p u l mo n a r y a l v e o l a r mi c r o l i t h i a s i s . Ar r o ws i n d i c a t e t h e f r a me s h i f t mu t a t i o n s .

F i g u r e 4 . T b a s e i n s e r t i o n o f S L C3 4 A2 g e n e t h a t c a u s e s f r a me s h i f t mu t a t i o n s i n h o mo z y g o u s ( s i b l i n g s 1 , 3 a n d 7 ) a n d h e t e r o z y g o u s me mb e r s ( b o t h p a r e n t s a n d s i b l i n g 8 ) o f t h e c u r r e n t f a mi l y .
Sibling 8.
A 21-year-old man, self-reported never-smoker and symptom-free. Chest radiography was normal, as well as physical examination and routine laboratory tests.
Testicular ultrasound was negative for microlithiasis in both man patients (index case and sibling 3) with PAM.
We could not evaluate siblings 2, 4, 5, and 6. Pedigree and mutations of the SLC34A2 in all available members of the family including the three siblings (1, 3 and 7) with pulmonary alveolar microlithiasis are shown in Fig. 3 .
Genotyping
Total genomic DNA was extracted from blood samples of all available family members by the invisorb kit extraction system (Invitex, Germany). Exons 1 and 2 of SLC34A2 gene were simultaneously amplified and directly sequenced.
The primer details were; SLC-exon1-2 F: 5´-CCACCCAGTTGATGCTTTGC-3Ś LC-exon1-2 R: 5´-GGGACAGGAGGATGATGACA-3Ṕ CR products were performed in a thermal cycler Applied Biosystem 2720. The profile consisted of an initial step of 5 minutes at 95 ; followed by 35 cycles of 30 seconds at 94 , 30 seconds at 58 , and 45 seconds at 72 ; and a final extension step of 10 minutes at 72 . Computer analyses of the PCR products (519 bps) were performed using custom programs and the nucleotide sequencing of products were made (AB, 310) for each person.
We found a T base insertion that causes a frame-shift in both alleles of exon 2 in three family members with PAM. The parents and one sibling were heterozygous for the mutation and were considered to be carriers ( Table 1 , Figs. 3, 4) . The parents were diagnosed as frame-shift mutation carriers. All family members were informed of the risks of consanguineous marriage.
Discussion
SLC34A2 (the type IIb sodium-phosphate cotransporter T a b l e 1 . S y mp t o ms o f Av a i l a b l e F a mi l y Me mb e r s ( n = 6 ) a n d Mu t a t i o n s i n t h e S L C3 4 A2 Ge n e gene) is highly expressed in the lung (specifically in type II alveolar cells), is directly related to calcium or phosphate metabolism, and the mutations abolish the normal gene function. Dysfunction of SLC34A2 may reduce the clearance of phosphate and may lead to the formation of microliths (9) . Corut et al identified homozygous mutations in SLC34A2 in a large family with PAM; however, the family had mild clinical phenotypes, with the exception of the smokers (8) . On the other hand, all three of the present cases with homozygous mutations were symptomatic and their chest radiographs revealed radiologically significant PAM with calcified microliths in both lungs.
Asymptomatic patients with PAM have frequently been reported (2, 3) , all three of our cases had complained of dyspnea on exertion but the heterozygous carriers (parents and one boy) were asymptomatic. These findings suggest that all siblings of any age of the index case should be examined for the presence of PAM.
As PAM has been reported in twins and siblings rather frequently (10) (11) (12) (13) , it has been suggested that genetic factors may be responsible for the disease. We identified homozygous (n=3 siblings) and heterozygous (n=3, both parents and one sibling) frame-shift mutations in the SLC34A2 gene in a ten-member family. All siblings with the homozygous muta-tion in the SLC34A2 (n=3) were diagnosed with PAM. Homozygous frame-shift mutation in the SLC34A2 gene was reported in seven unrelated patients with PAM by Corut et al (8) . A mutation in the SLC34A2 gene was presented in all six Japanese patients reported by Huqun and colleagues (9) . More recently, by a genome-wide SNP study, Ishihara et al (14) detected an intragenetic deletion in SLC34A2 of a case with pulmonary alveolar microlithiasis. We identified frame-shift mutations in SLC34A2 gene by directly sequencing technique in affected patients. Our results support the role of mutations of the SLC34A2 gene in the diagnosis of PAM. The truncated and/or absence of functional protein that encode by SLC34A2 gene is compatible with calcium phosphate deposition in alveolar cells in the current three first degree probands and causes full penetrance of PAM.
Conclusion
As consanguineous marriages are relatively frequent in some regions of the world, siblings of a patient with PAM should be carefully examined for PAM and for mutations in SLC34A2 gene in these regions. All families with PAM or a mutation in SLC34A2 gene should be informed about the risks of consanguineous marriage.
